Last week's American Academy of Pediatrics' (AAP) recommendation over Statin drug use in kids is still creating a firestorm. Over the weekend, Tara Parker-Pope at the NYT posted about her thoughts on why the AAP came up with such an extreme recommendation and wrote this: The new guidelines have raised questions about the pharmaceutical industry's ties to both the A.A.P. and the members of the group's nutrition committee that made the recommendations. But the A.A.P. asserted last week that there is no involvement by any commercial entity in the development of any statement or report it is... » Original link |
